C TRANSMISSION (00658): Li Zubin appointed as executive director and member of the Remuneration Committee.
China High Speed (00658) announced that, starting from January 16, 2026, Mr. Li Zubin has been appointed as an executive director and member of the remuneration committee of the company; Mr. Xie Wenjie has been appointed as an independent non-executive director and member of the remuneration committee of the company; Mr. Lu Yuanzhu has been appointed as an independent non-executive director, chairman of the nomination committee, and member of the audit committee of the company; Mr. Liu Zhengyang has been appointed as an independent non-executive director and chairman of the audit committee of the company.
C TRANSMISSION (00658) announces that, starting from January 16, 2026, Mr. Li Zubin has been appointed as an executive director and member of the Remuneration Committee of the company; Mr. Xie Wenjie has been appointed as an independent non-executive director and member of the Remuneration Committee; Mr. Lu Yuanzhu has been appointed as an independent non-executive director, Chairman of the Nomination Committee, and member of the Audit Committee; Mr. Liu Zhengyang has been appointed as an independent non-executive director and Chairman of the Audit Committee.
In addition, Mr. Hu Jichun has resigned as an executive director, Chairman of the Board, and Chairman of the Nomination Committee of the company; Mr. Chen Yongdao has resigned as an executive director and member of the Remuneration Committee; Mr. Zhou Zhijin has resigned as an executive director; Ms. Zheng Qing has resigned as an executive director; Mr. Gu Xiaobin has resigned as an executive director; Mr. Jiang Xihe has resigned as an independent non-executive director, Chairman of the Audit Committee, member of the Remuneration Committee, and member of the Nomination Committee; Dr. Chen Youzheng has resigned as an independent non-executive director, member of the Audit Committee, and Chairman of the Remuneration Committee; and Mr. Nathan Yu Li has resigned as an independent non-executive director, member of the Audit Committee, and member of the Nomination Committee.
Related Articles

Haisco Pharmaceutical Group (002653.SZ): Innovative drug HSK31679 tablet included in breakthrough therapy program.

Yinbang Clad Material (300337.SZ) is planning to register and issue medium-term notes.

HK Stock Market Move | NATURAL FOOD IH(01837) continues to rise by over 5%, offline channel business significantly grows, with annual net profit increasing by approximately 40% compared to the previous year.
Haisco Pharmaceutical Group (002653.SZ): Innovative drug HSK31679 tablet included in breakthrough therapy program.

Yinbang Clad Material (300337.SZ) is planning to register and issue medium-term notes.

HK Stock Market Move | NATURAL FOOD IH(01837) continues to rise by over 5%, offline channel business significantly grows, with annual net profit increasing by approximately 40% compared to the previous year.

RECOMMEND

“A+H” Team Continues To Expand Hard Technology Firms Accelerate Global Deployment
11/03/2026

Anti‑Stagflation Theme Guides Hong Kong Allocation Institutions Identify Power And Energy Assets As Short‑Term Core
11/03/2026

U.S. Equities Enter “Always‑On” Trading Era Nasdaq Advances Stock Tokenization Framework
11/03/2026


